These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 30782608)

  • 21. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Icariin induces irisin/FNDC5 expression in C2C12 cells via the AMPK pathway.
    Chen SQ; Ding LN; Zeng NX; Liu HM; Zheng SH; Xu JW; Li RM
    Biomed Pharmacother; 2019 Jul; 115():108930. PubMed ID: 31055234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
    Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
    J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function.
    Nam DH; Kim E; Benham A; Park HK; Soibam B; Taffet GE; Kaelber JT; Suh JH; Taegtmeyer H; Entman ML; Reineke EL
    FASEB J; 2019 Jan; 33(1):711-721. PubMed ID: 30024790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms.
    Zhuo C; Xin J; Huang W; Zhang D; Yan X; Li R; Li H; Lan J; Lin L; Li L; Wang X; Liu L; Wang Y; Li X; Mao Y; Chen H; Wu S; Yang X; Jiang W
    Toxicology; 2023 Aug; 494():153597. PubMed ID: 37499777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance.
    Zerlotin R; Fornaro M; Errede M; Pignataro P; Suriano C; Ruggieri M; Colucci S; Iannone F; Grano M; Colaianni G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irisin ameliorates angiotensin II-induced cardiomyocyte apoptosis through autophagy.
    Li R; Wang X; Wu S; Wu Y; Chen H; Xin J; Li H; Lan J; Xue K; Li X; Zhuo C; He J; Tang CS; Jiang W
    J Cell Physiol; 2019 Aug; 234(10):17578-17588. PubMed ID: 30793300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
    Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
    J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction.
    Fassett J; Xu X; Kwak D; Zhu G; Fassett EK; Zhang P; Wang H; Mayer B; Bache RJ; Chen Y
    J Mol Cell Cardiol; 2019 May; 130():49-58. PubMed ID: 30910669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
    Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
    Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Icariin inhibits isoproterenol-induced cardiomyocyte hypertropic injury through activating autophagy via the AMPK/mTOR signaling pathway.
    Hu L; Wang Z; Li H; Wei J; Tang F; Wang Q; Wang J; Zhang X; Zhang Q
    Biochem Biophys Res Commun; 2022 Feb; 593():65-72. PubMed ID: 35063771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
    Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
    Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic Acid Increases Fatty Acid Oxidation and Irisin Expression in Skeletal Muscle Cells and Impacts Irisin In Vivo.
    Amengual J; García-Carrizo FJ; Arreguín A; Mušinović H; Granados N; Palou A; Bonet ML; Ribot J
    Cell Physiol Biochem; 2018; 46(1):187-202. PubMed ID: 29587291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
    Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
    PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy.
    Liu X; Li B; Wang S; Zhang E; Schultz M; Touma M; Monteiro Da Rocha A; Evans SM; Eichmann A; Herron T; Chen R; Xiong D; Jaworski A; Weiss S; Si MS
    Circ Res; 2024 Mar; 134(7):913-930. PubMed ID: 38414132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calhex₂₃₁ Ameliorates Cardiac Hypertrophy by Inhibiting Cellular Autophagy in Vivo and in Vitro.
    Liu L; Wang C; Sun D; Jiang S; Li H; Zhang W; Zhao Y; Xi Y; Shi S; Lu F; Tian Y; Xu C; Wang L
    Cell Physiol Biochem; 2015; 36(4):1597-612. PubMed ID: 26159880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
    Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
    J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway.
    Chen X; Jiang X; Cheng C; Chen J; Huang S; Xu M; Liu S
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):463-473. PubMed ID: 32394178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The RING-domain E3 ubiquitin ligase RNF146 promotes cardiac hypertrophy by suppressing the LKB1/AMPK signaling pathway.
    Sheng Z; Xu J; Li F; Yuan Y; Peng X; Chen S; Zhou R; Huang W
    Exp Cell Res; 2022 Jan; 410(1):112954. PubMed ID: 34856161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.